Keywords

Coronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Vaccination2019-20 coronavirus outbreakCoronavirusMedicineImmunologyDiseaseIntensive care medicineVirologyInfectious disease (medical specialty)Outbreak

Affiliated Institutions

Related Publications

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas , Frederick J. Angulo , John M. McLaughlin +12 more

Following the emergency use authorisation of the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel, the Ministry of Healt...

2021 The Lancet 1722 citations

SARS-CoV-2: a storm is raging

Savannah F. Pedersen , Ya‐Chi Ho

The pandemic coronavirus infectious disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading across the globe. In this is...

2020 Journal of Clinical Investigation 1206 citations

Publication Info

Year
2020
Type
review
Volume
20
Issue
10
Pages
615-632
Citations
1069
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1069
OpenAlex

Cite This

Mangalakumari Jeyanathan, Sam Afkhami, Fiona Smaill et al. (2020). Immunological considerations for COVID-19 vaccine strategies. Nature reviews. Immunology , 20 (10) , 615-632. https://doi.org/10.1038/s41577-020-00434-6

Identifiers

DOI
10.1038/s41577-020-00434-6